Concepedia

Luc Vranckx

LV

Statistics

Publications

12

Citations

2.2K

H-Index

11

Active since

1995

Affiliations

Janssen (Belgium)(Current)

Vrije Universiteit Amsterdam

Janssen (United States)

Johnson & Johnson (United States)

Dartmouth College

Luc Vranckx is an author at Janssen (Belgium) specializing in life sciences, microbiology, and atp synthase inhibition.

Publications per year

1995–2024

12

Publications

12

Diarylquinolines target subunit c of mycobacterial ATP synthase

Anil Koul, Najoua Dendouga, Karen Vergauwen et al. · Nature Chemical Biology · 2007 · 548 citations · Full text

, , +10

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline

Koen Andries, Cristina Villellas, Nele Coeck et al. · PLoS ONE · 2014 · 431 citations · Full text

, , +17

Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis

Anil Koul, Luc Vranckx, Najoua Dendouga et al. · Journal of Biological Chemistry · 2008 · 367 citations · Full text

, , +17

Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism

Anil Koul, Luc Vranckx, Neeraj Dhar et al. · Nature Communications · 2014 · 293 citations · Full text

, , +17

Molecular mechanism of respiratory syncytial virus fusion inhibitors

Michael B. Battles, Johannes P. M. Langedijk, Polina Furmanova-Hollenstein et al. · Nature Chemical Biology · 2015 · 171 citations · Full text

, , +14

1–5 of 12